Posted: August 21, 2023 Greetings Sidecar Fund II investors, and welcome aboard, for those investors who recently joined the Fund. The first half of 2023 has been a busy one for MABA. Top of the news was the finalization of the acquisition of one of MABA’s portfolio companies, Cerus Endovascular, by Stryker. MABA Sidecar Fund I investors, as well as members of MABA’s internal investment Pool II and several individual MABA members all received the first installment of their return from the investment. The acquisition was structured to include an up-front payment, followed by payments tied to the [ Read more... ]
Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies.
Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels.